PROGNOSTIC VALUE OF HIGH-SENSITIVITY CRP FOR CARDIOVASCULAR OUTCOMES IN TRA 2°P-TIMI 50

CV outcomes were evaluated by hsCRP at baseline and by change over time (baseline to 30 days) with a landmark analysis from 30 days to 3 yr. Results Recurrent CV events were more likely in pts with high baseline hsCRP (>=2mg/L) compared with low hsCRP (<2mg/L), including CV death/MI/stroke (11...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American College of Cardiology Vol. 61; no. 10; p. E1162
Main Authors May, Erin Bohula, Scirica, Benjamin, Bonaca, Marc, Murphy, Sabina, Braunwald, Eugene, Morrow, David
Format Journal Article
LanguageEnglish
Published New York Elsevier Inc 12.03.2013
Elsevier Limited
Subjects
Atherosclerosis
Cardiology
Cardiovascular
Internal Medicine
Medical research
Stroke
Online AccessGet full text

Cover

More Information
Summary:CV outcomes were evaluated by hsCRP at baseline and by change over time (baseline to 30 days) with a landmark analysis from 30 days to 3 yr. Results Recurrent CV events were more likely in pts with high baseline hsCRP (>=2mg/L) compared with low hsCRP (<2mg/L), including CV death/MI/stroke (11.5% vs. 8.4%, HR 1.37, p=<0.001), and other CV outcomes (Fig-L).
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(13)61162-6